How Do Targeted Therapies Change the Management of Indolent Lymphomas?
Prior to the advent of targeted therapies, there were few options other than chemotherapy for the treatment of patients with indolent B-cell lymphomas or chronic lymphocytic leukemia.
An 84-Year-Old Woman With an Indolent B-Cell Lymphoma
An 84-year-old woman with a history of Graves disease, hyperlipidemia, and hypertension presented to her physician with progressive fatigue and palpable bilateral axillary lymphadenopathy.